Cell MedX Corp
OTC:CMXC

Watchlist Manager
Cell MedX Corp Logo
Cell MedX Corp
OTC:CMXC
Watchlist
Price: 0.48 USD 1.27% Market Closed
Market Cap: $3.1m

Relative Value

CMXC doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of CMXC.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CMXC Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

CMXC Competitors Multiples
Cell MedX Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cell MedX Corp
OTC:CMXC
3.1m USD 0 -21.8 -12.6 -12.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD 19.5 68.3 52.1 63.6
US
Abbott Laboratories
NYSE:ABT
184.6B USD 4.2 13.2 16.9 23.5
US
Boston Scientific Corp
NYSE:BSX
135.6B USD 7 48.6 28.5 38.7
US
Stryker Corp
NYSE:SYK
134.5B USD 5.5 45.7 22.3 27
IE
Medtronic PLC
NYSE:MDT
128.9B USD 3.7 27.1 15.2 22
US
Becton Dickinson and Co
NYSE:BDX
57B USD 2.6 34.2 12.6 21.4
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR 2.1 22.5 12.8 18
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD 13.3 53.9 38.8 42.9
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 8.2 35.4 25.3 27.7
US
Resmed Inc
NYSE:RMD
36.6B USD 7 25.4 18.2 20.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cell MedX Corp
OTC:CMXC
Average EV/EBITDA: 24.3
Negative Multiple: -12.6
N/A N/A
US
Intuitive Surgical Inc
NASDAQ:ISRG
52.1
26%
2
US
Abbott Laboratories
NYSE:ABT
16.9
12%
1.4
US
Boston Scientific Corp
NYSE:BSX
28.5
22%
1.3
US
Stryker Corp
NYSE:SYK
22.3
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.2
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.6
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.3
13%
1.9
US
Resmed Inc
NYSE:RMD
18.2
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cell MedX Corp
OTC:CMXC
Average EV/EBIT: 30.5
Negative Multiple: -12.6
N/A N/A
US
Intuitive Surgical Inc
NASDAQ:ISRG
63.6
28%
2.3
US
Abbott Laboratories
NYSE:ABT
23.5
21%
1.1
US
Boston Scientific Corp
NYSE:BSX
38.7
32%
1.2
US
Stryker Corp
NYSE:SYK
27
16%
1.7
IE
Medtronic PLC
NYSE:MDT
22
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.4
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
18
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.9
15%
2.9
US
Edwards Lifesciences Corp
NYSE:EW
27.7
14%
2
US
Resmed Inc
NYSE:RMD
20.2
12%
1.7